 |
|
|
| |
Efficacy and Safety of Seladelpar in Patients With
Primary Biliary Cholangitis and Compensated Cirrhosis
in the Phase 3 Placebo-Controlled RESPONSE Trial
|
| |
| |
AASLD 2024 Nov 15-19 San Diego
Alejandra Villamil1, Ziad Younes2, Christopher L Bowlus3, John M Vierling4, Adam Vasura5, Andrea Galli6, Mordechai Rabinovitz7, Frederik Nevens8, Susheela Carroll9, Ke Yang9, Daria B Crittenden9, Charles A McWherter10, Eric J Lawitz11
|
| |
|
|
|
|
|
